Skip to main content
Premium Trial:

Request an Annual Quote

Viaken Systems Lands $13 Million in Additional Funding

SAN DIEGO, June 25 – Viaken Systems has received $13 million in second round equity funding, the company announced Monday.

The Gaithersburg, Maryland, bioinformatics company received the additional funding from several venture capital firms, including lead investor Sterling Venture Partners.

The money will support Viaken for 18 months, Keith Elliston, Viaken CEO, told GenomeWeb.

The company, currently with approximately 45 employees, plans to add about 55 more by year end, said Elliston. In that time the company also plans to add five more customers to its current base of about nine.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.